Form 4: Guardant Health CIO Reports Routine Stock Transactions, Including RSU Vesting and ESPP Acquisition

Guardant Health's Chief Information Officer, Kumud Kalia, reported standard equity transactions including the vesting of Restricted Stock Units and participation in the Employee Stock Purchase Plan, alongside a disposition of shares for tax withholding.

Summary

• Kumud Kalia, Chief Information Officer of Guardant Health, Inc. (GH), reported several stock transactions on June 1, 2025, as detailed in a Form 4 filing.
• Kalia acquired 710 shares of common stock through the vesting of Restricted Stock Units (RSUs) at a price of $0.
• Concurrently, 254 shares of common stock were disposed of at a price of $40.62 per share to satisfy tax withholding obligations related to the RSU vesting.
• Additionally, Table I indicates the acquisition of 859 shares under Guardant Health's Employee Stock Purchase Plan (ESPP) on May 14, 2025.
• Following these transactions, Kumud Kalia beneficially owns 22,765 shares of common stock and 711 Restricted Stock Units.
• The RSU award was originally granted on November 2, 2021, with 25% vesting on September 1, 2022, and the remaining 75% scheduled to vest in equal installments on each quarterly anniversary of September 1, 2022, over a three-year period.

Sentiment

Score: 7

Explanation: The filing indicates routine executive equity transactions, including vesting of RSUs and participation in an ESPP, which are generally positive as they align executive interests with shareholders. The disposition for tax withholding is a standard, neutral event. No negative operational or financial news is present.

Positives

• The acquisition of 710 shares of common stock through RSU vesting demonstrates the executive's continued equity participation and aligns their interests with long-term shareholder value.
• The acquisition of 859 shares via the Employee Stock Purchase Plan (ESPP) indicates the executive's ongoing investment in the company, suggesting confidence in its future prospects.

Negatives

• The disposition of 254 shares for tax withholding purposes, while a standard practice, results in a reduction of the executive's direct shareholding.

Future Outlook

The document does not provide forward-looking statements or guidance beyond the pre-defined vesting schedule of existing Restricted Stock Units.

Industry Context

This Form 4 filing is a routine insider transaction report and does not provide specific industry context. It reflects standard executive compensation practices involving equity awards and employee stock purchase plans common across various industries, particularly in high-growth technology and healthcare sectors like Guardant Health's.

Comparison to Industry Standards

• This document reports standard insider equity transactions (RSU vesting, tax withholding, ESPP acquisition). These types of transactions are common across publicly traded companies, especially in the biotechnology and diagnostics sector where equity compensation is a significant component of executive pay.
• There are no specific comparable companies, projects, or results mentioned to benchmark against, as this filing focuses on an individual's stock ownership changes rather than operational or financial performance.

Stakeholder Impact

• Shareholders: The transactions reflect standard executive compensation practices and an executive's continued equity ownership, aligning their interests with long-term shareholder value. The disposition for tax withholding is a common practice and does not indicate a lack of confidence.
• Employees: The Employee Stock Purchase Plan (ESPP) acquisition highlights the availability and utilization of employee benefit programs, which can be a positive for employee morale and retention.

Next Steps

• Continued quarterly vesting of the remaining 75% of the Restricted Stock Unit award on each quarterly anniversary of September 1, 2022, over a three-year period.

Key Dates

Recommendation

Keywords

Guardant Health, GH, Form 4, Insider Trading, Stock Transactions, Restricted Stock Units, RSU, Employee Stock Purchase Plan, ESPP, Executive Compensation, Beneficial Ownership